Million-dollar investment leads AGC Biologics to start new staff hunt – needs up to 300 new employees

Due to increased demand, AGC Biologics invest DKK 1.2bn in a new Danish factory. The contract manufacturer expects that the expanded production capacity will bring about a significant expansion of the staff group.
AGC Biologics Vice President, Technical Operations Christian Christensen. | Photo: AGC Biologics / PR-foto
AGC Biologics Vice President, Technical Operations Christian Christensen. | Photo: AGC Biologics / PR-foto
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN

Due to an increase in demands, AGC Biologics now chooses to establish a new factory at around DKK 1.2bn (USD 195.2m), which more than doubles the firm's Danish production capacity, according to AGC Biologics' Vice President, Technical Operations, Christian Christensen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading